This list is an analysis based on recent market events. It's not an investment recommendation.
Calidi Biotherapeutics Inc is a biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal sites of disease. The company's proprietary RedTail platform features an engineered enveloped oncolytic virus designed for systemic delivery and targeting of metastatic sites. Its technology is intended to shield the virus from immune clearance, allowing virotherapy to effectively reach tumor sites, induce tumor lysis, and deliver potent genetic medicine(s) to metastatic locations. Its product candidates include The RedTail for Metastatic Solid Tumors, CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-101 (NeuroNova) for Newly Diagnosed High Grade Glioma.
FAQs
What is Global X S&P 500 U.S. Market Leaders Top 50 stock price today?▼
The current price of FLAG.BOATS is $31.30 USD — it has increased by +0% in the past 24 hours. Watch Global X S&P 500 U.S. Market Leaders Top 50 stock price performance more closely on the chart.
What is Global X S&P 500 U.S. Market Leaders Top 50 stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boats exchange Global X S&P 500 U.S. Market Leaders Top 50 stocks are traded under the ticker FLAG.BOATS.
Does Global X S&P 500 U.S. Market Leaders Top 50 pay dividends?▼
Yes, FLAG.BOATS dividends are paid semi-annual. The last dividend per share was 0.24 . As of today, Dividend Yield (FWD)% is 2.27%.
In which sector is Global X S&P 500 U.S. Market Leaders Top 50 located?▼
Global X S&P 500 U.S. Market Leaders Top 50 operates in the Other sector.
When did Global X S&P 500 U.S. Market Leaders Top 50 complete a stock split?▼
Global X S&P 500 U.S. Market Leaders Top 50 has not had any recent stock splits.